Combined Utility of Platelet Indices, Procalcitonin, and qSOFA Score in Predicting Sepsis Outcomes: A Prospective Study
Abstract
Background: Sepsis remains a leading cause of morbidity and mortality worldwide, particularly in low-resource settings where expensive biomarkers are often impractical. Platelet indices, quick Sequential Organ Failure Assessment (qSOFA) score, and serum procalcitonin are readily available parameters that may improve prognostic accuracy in septic patients. Methods : A prospective cross-sectional study was conducted over three months at a tertiary care centre, enrolling 98 adult patients with sepsis and qSOFA ≥2. Clinical evaluation included calculation of qSOFA and SOFA scores. Blood samples were collected on days 1 and 3 for platelet indices (platelet count, mean platelet volume [MPV], platelet distribution width [PDW], plateletcrit [PCT], platelet large cell ratio [P-LCR]) and procalcitonin. Patients were followed until discharge or death. Statistical analysis was performed using SPSS v22, with ROC curves applied to evaluate predictive accuracy. Results : The mean age of patients was 54.3 ± 17.8 years, with overall in-hospital mortality of 22.4%. Thrombocytopenia was significantly more frequent among non-survivors (68.2% vs. 25.0%, p = 0.002). Platelet counts decreased in non-survivors while increasing among survivors from day 1 to day 3 (p < 0.001). Non-survivors demonstrated higher MPV (12.3 ± 1.4 vs. 11.0 ± 1.3 fL, p = 0.004) and PDW (13.6 ± 3.1 vs. 9.1 ± 2.0 fL, p < 0.001). Median procalcitonin levels were significantly elevated in non-survivors (4.6 vs. 1.4 ng/mL, p < 0.001). A qSOFA ≥2 was strongly associated with mortality (p < 0.001). ROC analysis showed that qSOFA alone predicted mortality with an AUC of 0.68, procalcitonin with 0.75, and platelet indices with 0.73. The best discrimination was achieved when qSOFA, procalcitonin, and platelet indices were combined (AUC 0.85; sensitivity 86%, specificity 78%). Conclusion : Platelet indices, when used in combination with qSOFA and procalcitonin, provide a simple, affordable, and reliable approach to predict outcomes in sepsis. Their integration into routine clinical practice may enhance early risk stratification, particularly in resource-limited settings.